<VariationArchive VariationID="1428058" VariationName="NM_003079.5(SMARCE1):c.808del (p.Arg272fs)" VariationType="Deletion" Accession="VCV001428058" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1464213" VariationID="1428058">
      <GeneList>
        <Gene Symbol="SMARCE1" FullName="SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1" GeneID="6605" HGNC_ID="HGNC:11109" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="40624962" stop="40647818" display_start="40624962" display_stop="40647818" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="38783971" stop="38804102" display_start="38783971" display_stop="38804102" Strand="-" />
          </Location>
          <OMIM>603111</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003079.5(SMARCE1):c.808del (p.Arg272fs)</Name>
      <CanonicalSPDI>NC_000017.11:40631599:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="40631600" stop="40631600" display_start="40631600" display_stop="40631600" variantLength="1" positionVCF="40631599" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="38787852" stop="38787852" display_start="38787852" display_stop="38787852" variantLength="1" positionVCF="38787851" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>R272fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.38787852del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.38787852del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.40631600del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.40631600del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032163.1" sequenceAccession="NG_032163" sequenceVersion="1" change="g.21252del">
            <Expression>NG_032163.1:g.21252del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003079.5" sequenceAccession="NM_003079" sequenceVersion="5" change="c.808del" MANESelect="true">
            <Expression>NM_003079.5:c.808del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003070.3" sequenceAccession="NP_003070" sequenceVersion="3" change="p.Arg272fs">
            <Expression>NP_003070.3:p.Arg272fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2143986851" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003079.5(SMARCE1):c.808del (p.Arg272fs) AND Familial meningioma" Accession="RCV001936109" Version="3">
        <ClassifiedConditionList TraitSetID="6615">
          <ClassifiedCondition DB="MedGen" ID="C3551915">Familial meningioma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-10-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23377182</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26803492</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6615" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2843" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial meningioma</ElementValue>
                <XRef ID="MONDO:0011789" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Meningioma, familial, susceptibility to</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Individuals with MN1 C-terminal truncation (MCTT) syndrome have mild-to-moderate intellectual disability, severe expressive language delay, dysmorphic facial features (midface hypoplasia, downslanting palpebral fissures, hypertelorism, exophthalmia, short upturned nose, and small low-set ears), and distinctive findings on brain imaging (including perisylvian polymicrogyria and atypical rhombencephalosynapsis). Mild-to-moderate prelingual hearing loss (usually bilateral, conductive, and/or sensorineural) is common. Generalized seizures (observed in the minority of individuals) are responsive to anti-seizure medication. There is an increased risk for craniosynostosis and, thus, increased intracranial pressure. To date, 25 individuals with MCTT syndrome have been identified.</Attribute>
                <XRef ID="NBK560443" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18385" />
                <XRef ID="18385" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">32790267</ID>
                <ID Source="BookShelf">NBK560443</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng99</URL>
                <CitationText>UK NICE Guideline NG99, Brain tumours (primary) and brain metastases in over 16s, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ®) Central Nervous System Cancers, 2023</CitationText>
              </Citation>
              <XRef ID="263662" DB="Orphanet" />
              <XRef ID="C3551915" DB="MedGen" />
              <XRef ID="MONDO:0011789" DB="MONDO" />
              <XRef Type="MIM" ID="607174" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4220138" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="15065282|MedGen:C1333989" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002201588" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26803492</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23377182</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with meningioma (PMID: 26803492). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg272Glyfs*5) in the SMARCE1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMARCE1 are known to be pathogenic (PMID: 23377182).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMARCE1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.38787852del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1333989" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4220138" TraitType="Disease" MappingType="XRef" MappingValue="C1333989" MappingRef="MedGen">
        <MedGen CUI="C3551915" Name="Familial meningioma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>